BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006;148:752-9. [PMID: 16751790 DOI: 10.1038/sj.bjp.0706789] [Cited by in Crossref: 283] [Cited by in F6Publishing: 279] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Barson JR, Leibowitz SF. Hypothalamic neuropeptide signaling in alcohol addiction. Prog Neuropsychopharmacol Biol Psychiatry 2016;65:321-9. [PMID: 25689818 DOI: 10.1016/j.pnpbp.2015.02.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
2 Marchant NJ, Millan EZ, McNally GP. The hypothalamus and the neurobiology of drug seeking. Cell Mol Life Sci 2012;69:581-97. [PMID: 21947443 DOI: 10.1007/s00018-011-0817-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
3 Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 2008;105:19480-5. [PMID: 19033203 DOI: 10.1073/pnas.0808023105] [Cited by in Crossref: 196] [Cited by in F6Publishing: 195] [Article Influence: 14.0] [Reference Citation Analysis]
4 Robinson DL, Amodeo LR, Chandler LJ, Crews FT, Ehlers CL, Gómez-A A, Healey KL, Kuhn CM, Macht VA, Marshall SA, Swartzwelder HS, Varlinskaya EI, Werner DF. The role of sex in the persistent effects of adolescent alcohol exposure on behavior and neurobiology in rodents. Int Rev Neurobiol 2021;160:305-40. [PMID: 34696877 DOI: 10.1016/bs.irn.2021.07.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Richardson KA, Aston-Jones G. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J Neurosci 2012;32:3809-17. [PMID: 22423101 DOI: 10.1523/JNEUROSCI.3917-11.2012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
6 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010;100:419-28. [PMID: 20338186 DOI: 10.1016/j.physbeh.2010.03.009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 150] [Article Influence: 12.9] [Reference Citation Analysis]
7 Lopez MF, Moorman DE, Aston-Jones G, Becker HC. The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain Res 2016;1636:74-80. [PMID: 26851547 DOI: 10.1016/j.brainres.2016.01.049] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
8 Lawrence AJ. Factors regulating stress-induced alcohol-seeking and pharmacotherapeutic treatments. Alcohol 2009;43:545-6. [DOI: 10.1016/j.alcohol.2009.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Reichelt AC, Westbrook RF, Morris MJ. Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses. Br J Pharmacol 2015;172:5225-38. [PMID: 26403657 DOI: 10.1111/bph.13321] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kastman HE, Blasiak A, Walker L, Siwiec M, Krstew EV, Gundlach AL, Lawrence AJ. Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats. Neuropharmacology 2016;110:82-91. [PMID: 27395787 DOI: 10.1016/j.neuropharm.2016.07.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
11 Sahafzadeh M, Karimi-Haghighi S, Mousavi Z, Haghparast A. Role of the orexin receptors within the nucleus accumbens in the drug priming-induced reinstatement of morphine seeking in the food deprived rats. Brain Res Bull 2018;137:217-24. [PMID: 29258865 DOI: 10.1016/j.brainresbull.2017.12.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
12 Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008;199:109-17. [PMID: 18470506 DOI: 10.1007/s00213-008-1136-5] [Cited by in Crossref: 166] [Cited by in F6Publishing: 178] [Article Influence: 11.9] [Reference Citation Analysis]
13 Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11. [PMID: 19948148 DOI: 10.1016/j.brainres.2009.11.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
14 Morganstern I, Chang GQ, Barson JR, Ye Z, Karatayev O, Leibowitz SF. Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res 2010;34:886-96. [PMID: 20331576 DOI: 10.1111/j.1530-0277.2010.01161.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
15 Wiskerke J, James MH, Aston-Jones G. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Res 2020;1731:146222. [PMID: 31002819 DOI: 10.1016/j.brainres.2019.04.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
16 Low LA, Fitzgerald M. Acute pain and a motivational pathway in adult rats: influence of early life pain experience. PLoS One 2012;7:e34316. [PMID: 22470556 DOI: 10.1371/journal.pone.0034316] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
17 Brown RM, Lawrence AJ. Ascending orexinergic pathways and alcohol-seeking. Curr Opin Neurobiol 2013;23:467-72. [PMID: 23537903 DOI: 10.1016/j.conb.2013.02.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
18 Macedo GC, Kawakami SE, Vignoli T, Sinigaglia-Coimbra R, Suchecki D. The influence of orexins on ethanol-induced behavioral sensitization in male mice. Neurosci Lett 2013;551:84-8. [PMID: 23880022 DOI: 10.1016/j.neulet.2013.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
19 Perrey DA, Decker AM, Li JX, Gilmour BP, Thomas BF, Harris DL, Runyon SP, Zhang Y. The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Bioorg Med Chem 2015;23:5709-24. [PMID: 26216017 DOI: 10.1016/j.bmc.2015.07.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
20 Sharf R, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Res 2010;1317:24-32. [PMID: 20034477 DOI: 10.1016/j.brainres.2009.12.035] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
21 Stettner GM, Kubin L, Volgin DV. Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period. Behav Brain Res 2011;221:324-8. [PMID: 21420437 DOI: 10.1016/j.bbr.2011.03.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
22 Perrey DA, German NA, Gilmour BP, Li JX, Harris DL, Thomas BF, Zhang Y. Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. J Med Chem 2013;56:6901-16. [PMID: 23941044 DOI: 10.1021/jm400720h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
23 Carvajal F, Alcaraz-iborra M, Lerma-cabrera JM, Valor LM, de la Fuente L, Sanchez-amate MDC, Cubero I. Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence. Behavioural Brain Research 2015;287:230-7. [DOI: 10.1016/j.bbr.2015.03.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
24 Di Sebastiano AR, Wilson-pérez HE, Lehman MN, Coolen LM. Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats. Hormones and Behavior 2011;59:1-8. [DOI: 10.1016/j.yhbeh.2010.09.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
25 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
26 Hollander JA, Pham D, Fowler CD, Kenny PJ. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 2012;6:47. [PMID: 22837742 DOI: 10.3389/fnbeh.2012.00047] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
27 Hirota K, Kushikata T, Yoshida H, Kudo M, Kudo T. Role of the orexinergic system in acute haemorrhage in the rat. Neuroscience Letters 2008;432:162-6. [DOI: 10.1016/j.neulet.2007.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Srinivasan S, Shariff M, Bartlett SE. The role of the glucocorticoids in developing resilience to stress and addiction. Front Psychiatry 2013;4:68. [PMID: 23914175 DOI: 10.3389/fpsyt.2013.00068] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
29 Khoo SY, McNally GP, Clemens KJ. The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking. PLoS One 2017;12:e0173967. [PMID: 28296947 DOI: 10.1371/journal.pone.0173967] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
30 Brown RM, Short JL, Lawrence AJ. Identification of brain nuclei implicated in cocaine-primed reinstatement of conditioned place preference: a behaviour dissociable from sensitization. PLoS One 2010;5:e15889. [PMID: 21209913 DOI: 10.1371/journal.pone.0015889] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
31 Butelman ER, Kreek MJ. Medications for substance use disorders (SUD): emerging approaches. Expert Opin Emerg Drugs 2017;22:301-15. [PMID: 29057665 DOI: 10.1080/14728214.2017.1395855] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
32 Martin-Fardon R, Weiss F. Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking. Neuroreport 2014;25:485-8. [PMID: 24407199 DOI: 10.1097/WNR.0000000000000120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
33 Cowen MS, Krstew E, Lawrence AJ. Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism. Psychopharmacology 2007;190:21-9. [DOI: 10.1007/s00213-006-0583-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
34 Bayerlein K, Kraus T, Leinonen I, Pilniok D, Rotter A, Hofner B, Schwitulla J, Sperling W, Kornhuber J, Biermann T. Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal. Alcohol 2011;45:541-7. [DOI: 10.1016/j.alcohol.2011.02.306] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
35 Nair SG, Golden SA, Shaham Y. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br J Pharmacol 2008;154:406-16. [PMID: 18223663 DOI: 10.1038/bjp.2008.3] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 7.2] [Reference Citation Analysis]
36 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014;8:36. [PMID: 24616658 DOI: 10.3389/fnins.2014.00036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
37 Anderson RI, Becker HC, Adams BL, Jesudason CD, Rorick-Kehn LM. Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models. Front Neurosci 2014;8:33. [PMID: 24616657 DOI: 10.3389/fnins.2014.00033] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
38 Campbell EJ, Marchant NJ, Lawrence AJ. A sleeping giant: Suvorexant for the treatment of alcohol use disorder? Brain Res 2020;1731:145902. [PMID: 30081035 DOI: 10.1016/j.brainres.2018.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
39 Adams CL, Short JL, Lawrence AJ. Cue-conditioned alcohol seeking in rats following abstinence: involvement of metabotropic glutamate 5 receptors. Br J Pharmacol 2010;159:534-42. [PMID: 20067474 DOI: 10.1111/j.1476-5381.2009.00562.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
40 Prince CD, Rau AR, Yorgason JT, España RA. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. ACS Chem Neurosci 2015;6:138-46. [PMID: 25496218 DOI: 10.1021/cn500246j] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
41 Ubaldi M, Giordano A, Severi I, Li H, Kallupi M, de Guglielmo G, Ruggeri B, Stopponi S, Ciccocioppo R, Cannella N. Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S. Biol Psychiatry 2016;79:452-62. [PMID: 26055195 DOI: 10.1016/j.biopsych.2015.04.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
42 Brown RM, Kim AK, Khoo SY, Kim JH, Jupp B, Lawrence AJ. Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats: Orexin and alcohol-seeking. Addiction Biology 2016;21:603-12. [DOI: 10.1111/adb.12251] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
43 Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
44 Ponté C, Giron A, Crequy M, Lapeyre-Mestre M, Fabre N, Salles J. Cluster Headache in Subjects With Substance Use Disorder: A Case Series and a Review of the Literature. Headache 2019;59:576-89. [PMID: 30957220 DOI: 10.1111/head.13516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Barson JR, Leibowitz SF. Orexin/Hypocretin System: Role in Food and Drug Overconsumption. Int Rev Neurobiol 2017;136:199-237. [PMID: 29056152 DOI: 10.1016/bs.irn.2017.06.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
46 Linehan V, Rowe TM, Hirasawa M. Dopamine modulates excitatory transmission to orexin neurons in a receptor subtype-specific manner. Am J Physiol Regul Integr Comp Physiol 2019;316:R68-75. [PMID: 30462527 DOI: 10.1152/ajpregu.00150.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Blackburn AN, Hajnal A, Leggio L. The gut in the brain: the effects of bariatric surgery on alcohol consumption. Addict Biol 2017;22:1540-53. [PMID: 27578259 DOI: 10.1111/adb.12436] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
48 Campbell EJ, Norman A, Bonomo Y, Lawrence AJ. Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial. Brain Res 2020;1728:146597. [PMID: 31837287 DOI: 10.1016/j.brainres.2019.146597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
49 Fortuyn HA, Lappenschaar GA, Nienhuis FJ, Furer JW, Hodiamont PP, Rijnders CA, Lammers GJ, Renier WO, Buitelaar JK, Overeem S. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry 2009;31:146-54. [PMID: 19269535 DOI: 10.1016/j.genhosppsych.2008.12.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
50 Christopher JA. Small-molecule antagonists of the orexin receptors. Pharm Pat Anal 2014;3:625-38. [PMID: 25489915 DOI: 10.4155/ppa.14.46] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
51 Cannella N, Ubaldi M, Masi A, Bramucci M, Roberto M, Bifone A, Ciccocioppo R. Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neurosci Biobehav Rev 2019;103:384-98. [PMID: 31112713 DOI: 10.1016/j.neubiorev.2019.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
52 Borgland SL, Storm E, Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 2008;28:1545-56. [PMID: 18793323 DOI: 10.1111/j.1460-9568.2008.06397.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 6.9] [Reference Citation Analysis]
53 Perry CJ, Zbukvic I, Kim JH, Lawrence AJ. Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol 2014;171:4636-72. [PMID: 24749941 DOI: 10.1111/bph.12735] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
54 Ubaldi M, Cannella N, Ciccocioppo R. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics. Prog Brain Res 2016;224:251-84. [PMID: 26822362 DOI: 10.1016/bs.pbr.2015.07.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
55 Marchant NJ, Hamlin AS, McNally GP. Lateral hypothalamus is required for context-induced reinstatement of extinguished reward seeking. J Neurosci 2009;29:1331-42. [PMID: 19193880 DOI: 10.1523/JNEUROSCI.5194-08.2009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
56 Sharf R, Sarhan M, Dileone RJ. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008;64:175-83. [PMID: 18423425 DOI: 10.1016/j.biopsych.2008.03.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
57 Chang GQ, Karatayev O, Leibowitz SF. Prenatal exposure to nicotine stimulates neurogenesis of orexigenic peptide-expressing neurons in hypothalamus and amygdala. J Neurosci 2013;33:13600-11. [PMID: 23966683 DOI: 10.1523/JNEUROSCI.5835-12.2013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
58 Gass JT, Olive MF. Neurochemical and neurostructural plasticity in alcoholism. ACS Chem Neurosci 2012;3:494-504. [PMID: 22896799 DOI: 10.1021/cn300013p] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
59 Huang M, Chen C, Chen L, Chang H, Chen C, Lin S, Xu K. Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation. Psychopharmacology 2020;237:45-53. [DOI: 10.1007/s00213-019-05342-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
60 Alcaraz-iborra M, Cubero I. Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug/food dependence? Pharmacology Biochemistry and Behavior 2015;134:31-4. [DOI: 10.1016/j.pbb.2015.04.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
61 Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
62 Łupina M, Tarnowski M, Baranowska-Bosiacka I, Talarek S, Listos P, Kotlińska J, Gutowska I, Listos J. SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice-a View on Receptor Mechanisms. Mol Neurobiol 2018;55:8473-85. [PMID: 29557083 DOI: 10.1007/s12035-018-0993-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
63 Shalev U, Erb S, Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 2010;1314:15-28. [PMID: 19631614 DOI: 10.1016/j.brainres.2009.07.028] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
64 Vengeliene V, Bilbao A, Molander A, Spanagel R. Neuropharmacology of alcohol addiction. Br J Pharmacol 2008;154:299-315. [PMID: 18311194 DOI: 10.1038/bjp.2008.30] [Cited by in Crossref: 361] [Cited by in F6Publishing: 332] [Article Influence: 25.8] [Reference Citation Analysis]
65 Plaza-Zabala A, Flores Á, Martín-García E, Saravia R, Maldonado R, Berrendero F. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology 2013;38:1724-36. [PMID: 23518606 DOI: 10.1038/npp.2013.72] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
66 Mehr JB, Mitchison D, Bowrey HE, James MH. Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link. Neuropsychopharmacology 2021. [PMID: 34145404 DOI: 10.1038/s41386-021-01052-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Laorden ML, Ferenczi S, Pintér-Kübler B, González-Martín LL, Lasheras MC, Kovács KJ, Milanés MV, Núñez C. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One 2012;7:e36871. [PMID: 22590628 DOI: 10.1371/journal.pone.0036871] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
68 Quarta D, Valerio E, Hutcheson DM, Hedou G, Heidbreder C. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochemistry International 2010;56:11-5. [DOI: 10.1016/j.neuint.2009.08.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
69 Radke AK, Sneddon EA, Frasier RM, Hopf FW. Recent Perspectives on Sex Differences in Compulsion-Like and Binge Alcohol Drinking. Int J Mol Sci 2021;22:3788. [PMID: 33917517 DOI: 10.3390/ijms22073788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Yang N, Anapindi KDB, Rubakhin SS, Wei P, Yu Q, Li L, Kenny PJ, Sweedler JV. Neuropeptidomics of the Rat Habenular Nuclei. J Proteome Res 2018;17:1463-73. [PMID: 29518334 DOI: 10.1021/acs.jproteome.7b00811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
71 Collier AD, Halkina V, Min SS, Roberts MY, Campbell SD, Camidge K, Leibowitz SF. Embryonic Ethanol Exposure Affects the Early Development, Migration, and Location of Hypocretin/Orexin Neurons in Zebrafish. Alcohol Clin Exp Res 2019;43:1702-13. [PMID: 31206717 DOI: 10.1111/acer.14126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
72 Madaan P, Behl T, Sehgal A, Singh S, Sharma N, Yadav S, Kaur S, Bhatia S, Al-harrasi A, Abdellatif AAH, Ashraf GM, Abdel-daim MM, Dailah HG, Anwer MK, Bungau S. Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy. Neurotox Res. [DOI: 10.1007/s12640-022-00477-8] [Reference Citation Analysis]
73 Poirier S, Legris G, Tremblay P, Michea R, Viau-guay L, Mérette C, Bouchard R, Maziade M, Roy M. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse. Schizophrenia Research 2010;118:285-91. [DOI: 10.1016/j.schres.2009.12.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
74 Mcpherson CS, Featherby T, Krstew E, Andrew JL. Quantification of Phosphorylated cAMP-Response Element-Binding Protein Expression throughout the Brain of Amphetamine-Sensitized Rats: Activation of Hypothalamic Orexin A-Containing Neurons. J Pharmacol Exp Ther 2007;323:805-12. [DOI: 10.1124/jpet.107.125732] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
75 Karnani M, Burdakov D. Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol 2011;300:R47-55. [PMID: 21048078 DOI: 10.1152/ajpregu.00527.2010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
76 Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol 2008;154:343-57. [PMID: 18414383 DOI: 10.1038/bjp.2008.133] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
77 Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF. Glutamatergic input to the lateral hypothalamus stimulates ethanol intake: role of orexin and melanin-concentrating hormone. Alcohol Clin Exp Res 2013;37:123-31. [PMID: 22823322 DOI: 10.1111/j.1530-0277.2012.01854.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
78 Smith RJ, Aston-Jones G. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 2012;35:798-804. [PMID: 22356621 DOI: 10.1111/j.1460-9568.2012.08013.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
79 Ryan PJ, Krstew EV, Sarwar M, Gundlach AL, Lawrence AJ. Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats. Drug Alcohol Depend 2014;140:8-16. [PMID: 24837581 DOI: 10.1016/j.drugalcdep.2014.04.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
80 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
81 Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, Ciccocioppo R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009;34:2125-34. [PMID: 19322167 DOI: 10.1038/npp.2009.37] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
82 Amodeo LR, Liu W, Wills DN, Vetreno RP, Crews FT, Ehlers CL. Adolescent alcohol exposure increases orexin-A/hypocretin-1 in the anterior hypothalamus. Alcohol 2020;88:65-72. [PMID: 32619610 DOI: 10.1016/j.alcohol.2020.06.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Matzeu A, Martin-Fardon R. Cocaine-Seeking Behavior Induced by Orexin A Administration in the Posterior Paraventricular Nucleus of the Thalamus Is Not Long-Lasting: Neuroadaptation of the Orexin System During Cocaine Abstinence. Front Behav Neurosci 2021;15:620868. [PMID: 33708078 DOI: 10.3389/fnbeh.2021.620868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Smith RJ, Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 2008;213:43-61. [PMID: 18651175 DOI: 10.1007/s00429-008-0191-3] [Cited by in Crossref: 152] [Cited by in F6Publishing: 150] [Article Influence: 10.9] [Reference Citation Analysis]
85 Pantazis CB, James MH, Bentzley BS, Aston-Jones G. The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addict Biol 2020;25:e12795. [PMID: 31297913 DOI: 10.1111/adb.12795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
86 Lawrence AJ. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 2010;1314:124-9. [PMID: 19646424 DOI: 10.1016/j.brainres.2009.07.072] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
87 Morales-mulia M. Intra-accumbal orexin-1 receptor inhibition prevents the anxiolytic-like effect of ethanol and leads to increases in orexin-A content and receptor expression. Pharmacology Biochemistry and Behavior 2019;185:172761. [DOI: 10.1016/j.pbb.2019.172761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
88 Moorman DE, Aston-Jones G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats. Alcohol 2009;43:379-86. [PMID: 19671464 DOI: 10.1016/j.alcohol.2009.07.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 7.3] [Reference Citation Analysis]
89 Jupp B, Krstew E, Dezsi G, Lawrence AJ. Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors. Br J Pharmacol 2011;162:880-9. [PMID: 20973776 DOI: 10.1111/j.1476-5381.2010.01088.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
90 Mendoza-Ruiz LG, Vázquez-León P, Martínez-Mota L, Juan ERS, Miranda-Páez A. Forced ethanol ingestion by Wistar rats from a juvenile age increased voluntary alcohol consumption in adulthood, with the involvement of orexin-A. Alcohol 2018;70:73-80. [PMID: 29803804 DOI: 10.1016/j.alcohol.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
91 Rainero I, Rubino E, Gallone S, Fenoglio P, Negro E, De Martino P, Savi L, Pinessi L. Cluster Headache is Associated With the Alcohol Dehydrogenase 4 ( ADH4 ) Gene. Headache: The Journal of Head and Face Pain 2010;50:92-8. [DOI: 10.1111/j.1526-4610.2009.01569.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
92 al'Absi M, Lemieux A, Hodges JS, Allen S. Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse. Addict Biol 2019;24:743-53. [PMID: 30117237 DOI: 10.1111/adb.12643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Janak PH, Chaudhri N. The Potent Effect of Environmental Context on Relapse to Alcohol-Seeking After Extinction. Open Addict J 2010;3:76-87. [PMID: 21132088 DOI: 10.2174/1874941001003010076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 23] [Article Influence: 0.1] [Reference Citation Analysis]
94 Moorman DE, James MH, Kilroy EA, Aston-Jones G. Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner. Eur J Neurosci 2016;43:710-20. [PMID: 26750264 DOI: 10.1111/ejn.13170] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 7.3] [Reference Citation Analysis]
95 Srinivasan S, Simms JA, Nielsen CK, Lieske SP, Bito-Onon JJ, Yi H, Hopf FW, Bonci A, Bartlett SE. The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PLoS One 2012;7:e44726. [PMID: 23028593 DOI: 10.1371/journal.pone.0044726] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
96 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 2015;172:334-48. [PMID: 24641197 DOI: 10.1111/bph.12639] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 12.1] [Reference Citation Analysis]
97 Baimel C, Borgland SL. Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse. Curr Top Behav Neurosci 2017;33:283-304. [PMID: 28303403 DOI: 10.1007/7854_2016_44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
98 Hamlin AS, Clemens KJ, McNally GP. Renewal of extinguished cocaine-seeking. Neuroscience 2008;151:659-70. [PMID: 18164822 DOI: 10.1016/j.neuroscience.2007.11.018] [Cited by in Crossref: 106] [Cited by in F6Publishing: 116] [Article Influence: 7.1] [Reference Citation Analysis]
99 Zhou L, Smith RJ, Do PH, Aston-Jones G, See RE. Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats. Neuropharmacology 2012;63:1201-7. [PMID: 22971541 DOI: 10.1016/j.neuropharm.2012.07.044] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
100 Ghanemi A, Hu X. Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies. Alexandria Journal of Medicine 2015;51:279-86. [DOI: 10.1016/j.ajme.2014.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
101 Ch’ng SS, Lawrence AJ. Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: A characterisation of OX1R-eGFP mice. Journal of Chemical Neuroanatomy 2015;66-67:1-9. [DOI: 10.1016/j.jchemneu.2015.03.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
102 Martin-Fardon R, Weiss F. N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea (SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking. Addict Biol 2014;19:233-6. [PMID: 22830647 DOI: 10.1111/j.1369-1600.2012.00480.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
103 Martin-Fardon R, Boutrel B. Orexin/hypocretin (Orx/Hcrt) transmission and drug-seeking behavior: is the paraventricular nucleus of the thalamus (PVT) part of the drug seeking circuitry? Front Behav Neurosci 2012;6:75. [PMID: 23162448 DOI: 10.3389/fnbeh.2012.00075] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
104 Calvez J, de Ávila C, Guèvremont G, Timofeeva E. Sex-Specific Effects of Chronic Administration of Relaxin-3 on Food Intake, Body Weight and the Hypothalamic-Pituitary-Gonadal Axis in Rats. J Neuroendocrinol 2016;28. [PMID: 27791297 DOI: 10.1111/jne.12439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
105 Engel JA, Jerlhag E. Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy. CNS Drugs 2014;28:875-86. [PMID: 24958205 DOI: 10.1007/s40263-014-0178-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
106 Morgan AJ, Harrod SB, Lacy RT, Stanley EM, Fadel JR. Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats. Drug Alcohol Depend 2013;132:562-70. [PMID: 23664126 DOI: 10.1016/j.drugalcdep.2013.04.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
107 Campbell EJ, Hill MK, Maddern XJ, Jin S, Pang TY, Lawrence AJ. Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking. J Psychopharmacol 2020;34:1261-70. [PMID: 33063594 DOI: 10.1177/0269881120959638] [Reference Citation Analysis]
108 Barson JR, Ho HT, Leibowitz SF. Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: role of orexin receptor 2. Addict Biol 2015;20:469-81. [PMID: 24712379 DOI: 10.1111/adb.12139] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
109 James MH, Bowrey HE, Stopper CM, Aston-Jones G. Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats. Eur J Neurosci 2019;50:2602-12. [PMID: 30240516 DOI: 10.1111/ejn.14166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
110 Perrey DA, Decker AM, Zhang Y. Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability. ACS Chem Neurosci 2018;9:587-602. [PMID: 29129052 DOI: 10.1021/acschemneuro.7b00402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
111 Corrigall WA. Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology (Berl) 2009;206:23-37. [PMID: 19529922 DOI: 10.1007/s00213-009-1588-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
112 Pan YP, Liu C, Liu MF, Wang Y, Bian K, Xue Y, Chen L. Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats. Neuropeptides 2020;80:102019. [PMID: 31980205 DOI: 10.1016/j.npep.2020.102019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
113 Davis JF, Tracy AL, Schurdak JD, Magrisso IJ, Grayson BE, Seeley RJ, Benoit SC. Roux en Y gastric bypass increases ethanol intake in the rat. Obes Surg 2013;23:920-30. [PMID: 23440511 DOI: 10.1007/s11695-013-0884-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
114 Koob GF. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Pharmacol Rev 2021;73:163-201. [PMID: 33318153 DOI: 10.1124/pharmrev.120.000083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
115 Prasad AA, McNally GP. Effects of vivo morpholino knockdown of lateral hypothalamus orexin/hypocretin on renewal of alcohol seeking. PLoS One 2014;9:e110385. [PMID: 25329297 DOI: 10.1371/journal.pone.0110385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
116 Matzeu A, Martin-Fardon R. Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats. Neuropharmacology 2020;164:107906. [PMID: 31841797 DOI: 10.1016/j.neuropharm.2019.107906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
117 Steiner MA, Lecourt H, Jenck F. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat. Int J Neuropsychopharmacol 2013;16:417-32. [PMID: 22436395 DOI: 10.1017/S1461145712000193] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
118 Nair SG, Adams-Deutsch T, Epstein DH, Shaham Y. The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.Prog Neurobiol. 2009;89:18-45. [PMID: 19497349 DOI: 10.1016/j.pneurobio.2009.05.003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 6.4] [Reference Citation Analysis]
119 Jiang R, Song X, Bali P, Smith A, Bayona CR, Lin L, Cameron MD, McDonald PH, Kenny PJ, Kamenecka TM. Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists. Bioorg Med Chem Lett 2012;22:3890-4. [PMID: 22617492 DOI: 10.1016/j.bmcl.2012.04.122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
120 Alcaraz-Iborra M, Navarrete F, Rodríguez-Ortega E, de la Fuente L, Manzanares J, Cubero I. Different Molecular/Behavioral Endophenotypes in C57BL/6J Mice Predict the Impact of OX1 Receptor Blockade on Binge-Like Ethanol Intake. Front Behav Neurosci 2017;11:186. [PMID: 29066961 DOI: 10.3389/fnbeh.2017.00186] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
121 Kwok C, Lei K, Pedrozo V, Anderson L, Ghotra S, Walsh M, Li L, Yu J, Hopf FW. Differential importance of nucleus accumbens Ox1Rs and AMPARs for female and male mouse binge alcohol drinking. Sci Rep 2021;11:231. [PMID: 33420199 DOI: 10.1038/s41598-020-79935-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
122 James MH, Aston-Jones G. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?". Brain Res 2020;1731:146665. [PMID: 31930996 DOI: 10.1016/j.brainres.2020.146665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
123 Cifani C, Di Bonaventura MVM, Ciccocioppo R, Massi M. Binge Eating in Female Rats Induced by Yo-Yo Dieting and Stress. In: Avena NM, editor. Animal Models of Eating Disorders. Totowa: Humana Press; 2013. pp. 27-49. [DOI: 10.1007/978-1-62703-104-2_3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
124 Millan EZ, Furlong TM, McNally GP. Accumbens shell-hypothalamus interactions mediate extinction of alcohol seeking. J Neurosci 2010;30:4626-35. [PMID: 20357113 DOI: 10.1523/JNEUROSCI.4933-09.2010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
125 Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res 2010;1314:74-90. [PMID: 19815001 DOI: 10.1016/j.brainres.2009.09.106] [Cited by in Crossref: 238] [Cited by in F6Publishing: 242] [Article Influence: 18.3] [Reference Citation Analysis]
126 von der Goltz C, Koopmann A, Dinter C, Richter A, Rockenbach C, Grosshans M, Nakovics H, Wiedemann K, Mann K, Winterer G, Kiefer F. Orexin and leptin are associated with nicotine craving: A link between smoking, appetite and reward. Psychoneuroendocrinology 2010;35:570-7. [DOI: 10.1016/j.psyneuen.2009.09.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
127 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
128 Barson JR, Carr AJ, Soun JE, Sobhani NC, Rada P, Leibowitz SF, Hoebel BG. Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol Clin Exp Res 2010;34:214-22. [PMID: 19951300 DOI: 10.1111/j.1530-0277.2009.01084.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
129 Khoo SY, Brown RM. Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA? CNS Drugs 2014;28:713-30. [PMID: 24942635 DOI: 10.1007/s40263-014-0179-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
130 Amodeo LR, Wills DN, Sanchez-Alavez M, Nguyen W, Conti B, Ehlers CL. Intermittent voluntary ethanol consumption combined with ethanol vapor exposure during adolescence increases drinking and alters other behaviors in adulthood in female and male rats. Alcohol 2018;73:57-66. [PMID: 30293056 DOI: 10.1016/j.alcohol.2018.04.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
131 Vengeliene V, Foo JC, Kim J. Translational approach to understanding momentary factors associated with alcohol consumption. Br J Pharmacol 2020;177:3878-97. [PMID: 32608068 DOI: 10.1111/bph.15180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Voorhees CM, Cunningham CL. Involvement of the orexin/hypocretin system in ethanol conditioned place preference. Psychopharmacology (Berl) 2011;214:805-18. [PMID: 21107540 DOI: 10.1007/s00213-010-2082-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
133 McGinn MA, Pantazis CB, Tunstall BJ, Marchette RCN, Carlson ER, Said N, Koob GF, Vendruscolo LF. Drug addiction co-morbidity with alcohol: Neurobiological insights. Int Rev Neurobiol 2021;157:409-72. [PMID: 33648675 DOI: 10.1016/bs.irn.2020.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Jupp B, Krivdic B, Krstew E, Lawrence AJ. The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Research 2011;1391:54-9. [DOI: 10.1016/j.brainres.2011.03.045] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 8.4] [Reference Citation Analysis]
135 Kim AK, Brown RM, Lawrence AJ. The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Front Behav Neurosci 2012;6:78. [PMID: 23189046 DOI: 10.3389/fnbeh.2012.00078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
136 España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 2010;31:336-48. [PMID: 20039943 DOI: 10.1111/j.1460-9568.2009.07065.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 162] [Article Influence: 12.7] [Reference Citation Analysis]
137 Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission. Prog Neurobiol 2013;100:48-59. [PMID: 23041581 DOI: 10.1016/j.pneurobio.2012.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
138 Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiä P, Dawe GS, Koulu M. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacol Rev 2015;67:872-1004. [DOI: 10.1124/pr.115.010967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
139 Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sci 2020;10:E226. [PMID: 32290110 DOI: 10.3390/brainsci10040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
140 Pickering C, Avesson L, Liljequist S, Lindblom J, Schiöth HB. The role of hypothalamic peptide gene expression in alcohol self-administration behavior. Peptides 2007;28:2361-71. [PMID: 17976860 DOI: 10.1016/j.peptides.2007.09.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
141 Chen YW, Morganstern I, Barson JR, Hoebel BG, Leibowitz SF. Differential role of D1 and D2 receptors in the perifornical lateral hypothalamus in controlling ethanol drinking and food intake: possible interaction with local orexin neurons. Alcohol Clin Exp Res 2014;38:777-86. [PMID: 24236888 DOI: 10.1111/acer.12313] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
142 Perrey DA, German NA, Decker AM, Thorn D, Li JX, Gilmour BP, Thomas BF, Harris DL, Runyon SP, Zhang Y. Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor. ACS Chem Neurosci 2015;6:599-614. [PMID: 25643283 DOI: 10.1021/cn500330v] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
143 Fragale JE, Pantazis CB, James MH, Aston-Jones G. The role of orexin-1 receptor signaling in demand for the opioid fentanyl. Neuropsychopharmacology 2019;44:1690-7. [PMID: 31112988 DOI: 10.1038/s41386-019-0420-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
144 Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009;29:11215-25. [PMID: 19741128 DOI: 10.1523/JNEUROSCI.6096-08.2009] [Cited by in Crossref: 245] [Cited by in F6Publishing: 162] [Article Influence: 18.8] [Reference Citation Analysis]
145 Matzeu A, Martin-fardon R. Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value. Front Behav Neurosci 2022;15:787595. [DOI: 10.3389/fnbeh.2021.787595] [Reference Citation Analysis]
146 Genders SG, Scheller KJ, Djouma E. Neuropeptide modulation of addiction: Focus on galanin. Neuroscience & Biobehavioral Reviews 2020;110:133-49. [DOI: 10.1016/j.neubiorev.2018.06.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
147 Juarez B, Han MH. Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure. Neuropsychopharmacology 2016;41:2424-46. [PMID: 26934955 DOI: 10.1038/npp.2016.32] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 11.7] [Reference Citation Analysis]
148 Mahoney MK, Barnes JH, Wiercigroch D, Olmstead MC. Pharmacological investigations of a yohimbine-impulsivity interaction in rats. Behav Pharmacol 2016;27:585-95. [PMID: 27509312 DOI: 10.1097/FBP.0000000000000251] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
149 Smith RJ, See RE, Aston-Jones G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 2009;30:493-503. [PMID: 19656173 DOI: 10.1111/j.1460-9568.2009.06844.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 151] [Article Influence: 12.1] [Reference Citation Analysis]
150 Ash BL, Zanatta SD, Williams SJ, Lawrence AJ, Djouma E. The galanin-3 receptor antagonist, SNAP 37889, reduces operant responding for ethanol in alcohol-preferring rats. Regul Pept 2011;166:59-67. [PMID: 20736033 DOI: 10.1016/j.regpep.2010.08.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
151 Madsen HB, Brown RM, Short JL, Lawrence AJ. Investigation of the neuroanatomical substrates of reward seeking following protracted abstinence in mice. J Physiol 2012;590:2427-42. [PMID: 22393250 DOI: 10.1113/jphysiol.2011.225219] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
152 Ehlers CL, Benedict J, Wills D, Sanchez-Alavez M. PSPH-D-18-00526: Effect of a dual orexin receptor antagonist (DORA-12) on sleep and event-related oscillations in rats exposed to ethanol vapor during adolescence. Psychopharmacology (Berl) 2020;237:2917-27. [PMID: 31659377 DOI: 10.1007/s00213-019-05371-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
153 Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, Carlezon WA. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences 2014;111:E1648-55. [DOI: 10.1073/pnas.1315542111] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 19.9] [Reference Citation Analysis]
154 Zarepour L, Komaki A, Shahidi S, Sarihi A, Haghparast A. Potentiation of rewarding properties of morphine by concurrent chemical stimulation of lateral hypothalamus in rats. Pharmacology Biochemistry and Behavior 2013;107:36-41. [DOI: 10.1016/j.pbb.2013.03.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
155 Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJ, Javitch JA, Lindsley CW, Winder DG. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 2012;37:2253-66. [PMID: 22617356 DOI: 10.1038/npp.2012.76] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
156 Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 2010;1314:145-61. [PMID: 20026088 DOI: 10.1016/j.brainres.2009.12.027] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
157 Ballaz S, Espinosa N, Bourin M. Does endogenous cholecystokinin modulate alcohol intake? Neuropharmacology 2021;193:108539. [PMID: 33794246 DOI: 10.1016/j.neuropharm.2021.108539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
158 Liedtke WB, McKinley MJ, Walker LL, Zhang H, Pfenning AR, Drago J, Hochendoner SJ, Hilton DL, Lawrence AJ, Denton DA. Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite. Proc Natl Acad Sci U S A 2011;108:12509-14. [PMID: 21746918 DOI: 10.1073/pnas.1109199108] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
159 Hopf FW. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors. Neuropharmacology 2020;168:108013. [PMID: 32092435 DOI: 10.1016/j.neuropharm.2020.108013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
160 Sterling ME, Karatayev O, Chang GQ, Algava DB, Leibowitz SF. Model of voluntary ethanol intake in zebrafish: effect on behavior and hypothalamic orexigenic peptides. Behav Brain Res 2015;278:29-39. [PMID: 25257106 DOI: 10.1016/j.bbr.2014.09.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
161 Mahler SV, Smith RJ, Aston-Jones G. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 2013;226:687-98. [PMID: 22411428 DOI: 10.1007/s00213-012-2681-5] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 9.6] [Reference Citation Analysis]
162 Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 2008;29:70-87. [PMID: 17910982 DOI: 10.1016/j.yfrne.2007.08.001] [Cited by in Crossref: 178] [Cited by in F6Publishing: 162] [Article Influence: 11.9] [Reference Citation Analysis]
163 Matzeu A, Martin-Fardon R. Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus. Front Neurol 2018;9:720. [PMID: 30210441 DOI: 10.3389/fneur.2018.00720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
164 Hargreaves GA, Wang EY, Lawrence AJ, Mcgregor IS. Beer promotes high levels of alcohol intake in adolescent and adult alcohol-preferring rats. Alcohol 2011;45:485-98. [DOI: 10.1016/j.alcohol.2010.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
165 Forray A, Sofuoglu M. Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol 2014;77:382-400. [PMID: 23039267 DOI: 10.1111/j.1365-2125.2012.04474.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
166 Schneider ER, Rada P, Darby RD, Leibowitz SF, Hoebel BG. Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcohol Clin Exp Res 2007;31:1858-65. [PMID: 17850217 DOI: 10.1111/j.1530-0277.2007.00510.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 114] [Article Influence: 7.3] [Reference Citation Analysis]
167 Lee DJ, Elias GJB, Lozano AM. Neuromodulation for the treatment of eating disorders and obesity. Ther Adv Psychopharmacol 2018;8:73-92. [PMID: 29399320 DOI: 10.1177/2045125317743435] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
168 Walker LC, Kastman HE, Koeleman JA, Smith CM, Perry CJ, Krstew EV, Gundlach AL, Lawrence AJ. Nucleus incertus corticotrophin-releasing factor 1 receptor signalling regulates alcohol seeking in rats. Addict Biol 2017;22:1641-54. [PMID: 27440230 DOI: 10.1111/adb.12426] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
169 Adams CL, Cowen MS, Short JL, Lawrence AJ. Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats. Int J Neuropsychopharm 2008;11. [DOI: 10.1017/s1461145707007845] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
170 Barson JR, Poon K, Ho HT, Alam MI, Sanzalone L, Leibowitz SF. Substance P in the anterior thalamic paraventricular nucleus: promotion of ethanol drinking in response to orexin from the hypothalamus. Addict Biol 2017;22:58-69. [PMID: 26223289 DOI: 10.1111/adb.12288] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
171 Cason AM, Aston-Jones G. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist. Psychopharmacology (Berl) 2013;228:499-507. [PMID: 23494235 DOI: 10.1007/s00213-013-3051-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
172 Aujla H, Cannarsa R, Romualdi P, Ciccocioppo R, Martin-Fardon R, Weiss F. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal. Addict Biol 2013;18:467-79. [PMID: 22804785 DOI: 10.1111/j.1369-1600.2012.00466.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
173 Barson JR, Morganstern I, Leibowitz SF. Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. ILAR J 2012;53:35-58. [PMID: 23520598 DOI: 10.1093/ilar.53.1.35] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
174 Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8. [PMID: 19699189 DOI: 10.1016/j.brainres.2009.08.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
175 James MH, Stopper CM, Zimmer BA, Koll NE, Bowrey HE, Aston-Jones G. Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats. Biol Psychiatry 2019;85:925-35. [PMID: 30219208 DOI: 10.1016/j.biopsych.2018.07.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
176 Ch'ng S, Fu J, Brown RM, Mcdougall SJ, Lawrence AJ. The intersection of stress and reward: BNST modulation of aversive and appetitive states. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;87:108-25. [DOI: 10.1016/j.pnpbp.2018.01.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
177 Barson JR, Karatayev O, Chang GQ, Johnson DF, Bocarsly ME, Hoebel BG, Leibowitz SF. Positive relationship between dietary fat, ethanol intake, triglycerides, and hypothalamic peptides: counteraction by lipid-lowering drugs. Alcohol 2009;43:433-41. [PMID: 19801273 DOI: 10.1016/j.alcohol.2009.07.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
178 Davis JF, Choi DL, Benoit SC. Orexigenic Hypothalamic Peptides Behavior and Feeding. In: Preedy VR, Watson RR, Martin CR, editors. Handbook of Behavior, Food and Nutrition. New York: Springer; 2011. pp. 355-69. [DOI: 10.1007/978-0-387-92271-3_24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
179 Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010;67:753-60. [PMID: 20189166 DOI: 10.1016/j.biopsych.2009.12.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
180 Fragale JE, James MH, Aston-Jones G. Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system. Addict Biol 2021;26:e12946. [PMID: 32798290 DOI: 10.1111/adb.12946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
181 James MH, Mahler SV, Moorman DE, Aston-Jones G. A Decade of Orexin/Hypocretin and Addiction: Where Are We Now? Curr Top Behav Neurosci 2017;33:247-81. [PMID: 28012090 DOI: 10.1007/7854_2016_57] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
182 Plaza-Zabala A, Martín-García E, de Lecea L, Maldonado R, Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 2010;30:2300-10. [PMID: 20147556 DOI: 10.1523/JNEUROSCI.5724-09.2010] [Cited by in Crossref: 124] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
183 Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, Palmer J, Bonaventure P, Carruthers NI, Lovenberg TW, Boggs J, Galici R. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 2011;215:191-203. [DOI: 10.1007/s00213-010-2127-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
184 Marchant NJ, Furlong TM, McNally GP. Medial dorsal hypothalamus mediates the inhibition of reward seeking after extinction. J Neurosci 2010;30:14102-15. [PMID: 20962231 DOI: 10.1523/JNEUROSCI.4079-10.2010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
185 Walker LC, Ch’ng SS, Lawrence AJ. Role of Lateral Hypothalamic Orexin (Hypocretin) Neurons in Alcohol Use and Abuse: Recent Advances. Curr Pharmacol Rep 2016;2:241-52. [DOI: 10.1007/s40495-016-0069-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
186 Fragale JE, James MH, Avila JA, Spaeth AM, Aurora RN, Langleben D, Aston-Jones G. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System. Front Neurol Neurosci 2021;45:117-27. [PMID: 34052815 DOI: 10.1159/000514965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Jupp B, Lawrence AJ. New horizons for therapeutics in drug and alcohol abuse. Pharmacology & Therapeutics 2010;125:138-68. [DOI: 10.1016/j.pharmthera.2009.11.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
188 Harricharan R, Abboussi O, Daniels WM. Addiction: A dysregulation of satiety and inflammatory processes. Brain Research in Addiction. Elsevier; 2017. pp. 65-91. [DOI: 10.1016/bs.pbr.2017.07.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
189 Dhaher R, Hauser SR, Getachew B, Bell RL, McBride WJ, McKinzie DL, Rodd ZA. The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats. J Addict Med 2010;4:153-9. [PMID: 20871792 DOI: 10.1097/ADM.0b013e3181bd893f] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
190 Boutrel B, Steiner N, Halfon O. The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 2013;7:59. [PMID: 23781178 DOI: 10.3389/fnbeh.2013.00059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
191 Smith RJ, Tahsili-Fahadan P, Aston-Jones G. Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 2010;58:179-84. [PMID: 19591850 DOI: 10.1016/j.neuropharm.2009.06.042] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 8.1] [Reference Citation Analysis]
192 Luderer M, Ramos Quiroga JA, Faraone SV, Zhang James Y, Reif A. Alcohol use disorders and ADHD. Neurosci Biobehav Rev 2021;128:648-60. [PMID: 34265320 DOI: 10.1016/j.neubiorev.2021.07.010] [Reference Citation Analysis]
193 Arolfo MP, Overstreet DH, Yao L, Fan P, Lawrence AJ, Tao G, Keung WM, Vallee BL, Olive MF, Gass JT, Rubin E, Anni H, Hodge CW, Besheer J, Zablocki J, Leung K, Blackburn BK, Lange LG, Diamond I. Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res 2009;33:1935-44. [PMID: 19673742 DOI: 10.1111/j.1530-0277.2009.01031.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
194 Blasiak A, Siwiec M, Grabowiecka A, Blasiak T, Czerw A, Blasiak E, Kania A, Rajfur Z, Lewandowski MH, Gundlach AL. Excitatory orexinergic innervation of rat nucleus incertus--Implications for ascending arousal, motivation and feeding control. Neuropharmacology 2015;99:432-47. [PMID: 26265304 DOI: 10.1016/j.neuropharm.2015.08.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
195 Sterling ME, Chang GQ, Karatayev O, Chang SY, Leibowitz SF. Effects of embryonic ethanol exposure at low doses on neuronal development, voluntary ethanol consumption and related behaviors in larval and adult zebrafish: Role of hypothalamic orexigenic peptides. Behav Brain Res 2016;304:125-38. [PMID: 26778786 DOI: 10.1016/j.bbr.2016.01.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
196 Xu T, Yang Y, Ward R, Gao L, Liu Y. Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cellular Signalling 2013;25:2413-23. [DOI: 10.1016/j.cellsig.2013.07.025] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
197 Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF. Hypothalamic peptides controlling alcohol intake: differential effects on microstructure of drinking bouts. Alcohol 2014;48:657-64. [PMID: 25241055 DOI: 10.1016/j.alcohol.2014.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
198 James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, Smith DW, Dayas CV. Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 2011;14:684-90. [PMID: 21447232 DOI: 10.1017/S1461145711000423] [Cited by in Crossref: 89] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
199 Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol. 2008;154:261-274. [PMID: 18311189 DOI: 10.1038/bjp.2008.51] [Cited by in Crossref: 247] [Cited by in F6Publishing: 226] [Article Influence: 17.6] [Reference Citation Analysis]
200 Tran D, Bonaventure P, Hack M, Mirzadegan T, Dvorak C, Letavic M, Carruthers N, Lovenberg T, Sutton SW. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology 2011;667:120-8. [DOI: 10.1016/j.ejphar.2011.05.074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
201 Richards JK, Simms JA, Bartlett SE. Conditioned cues and yohimbine induce reinstatement of beer and near-beer seeking in Long-Evans rats. Addict Biol 2009;14:144-51. [PMID: 19076928 DOI: 10.1111/j.1369-1600.2008.00139.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
202 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
203 Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behav Brain Res 2011;217:446-53. [PMID: 20920531 DOI: 10.1016/j.bbr.2010.09.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
204 Campbell EJ, Lawrence AJ. It's more than just interoception: The insular cortex involvement in alcohol use disorder. J Neurochem 2021;157:1644-51. [PMID: 33486788 DOI: 10.1111/jnc.15310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Ryan PJ, Kastman HE, Krstew EV, Rosengren KJ, Hossain MA, Churilov L, Wade JD, Gundlach AL, Lawrence AJ. Relaxin-3/RXFP3 system regulates alcohol-seeking. Proc Natl Acad Sci U S A 2013;110:20789-94. [PMID: 24297931 DOI: 10.1073/pnas.1317807110] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
206 Sakurai T. The role of orexin in motivated behaviours. Nat Rev Neurosci 2014;15:719-31. [DOI: 10.1038/nrn3837] [Cited by in Crossref: 244] [Cited by in F6Publishing: 221] [Article Influence: 30.5] [Reference Citation Analysis]
207 Moorman DE, James MH, Kilroy EA, Aston-Jones G. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats. Brain Res 2017;1654:34-42. [PMID: 27771284 DOI: 10.1016/j.brainres.2016.10.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
208 Walker AW, Smith CM, Gundlach AL, Lawrence AJ. Relaxin-3 receptor ( Rxfp3 ) gene deletion reduces operant sucrose- but not alcohol-responding in mice: Rxfp3 gene deletion reduces operant sucrose- but not alcohol-responding in mice. Genes, Brain and Behavior 2015;14:625-34. [DOI: 10.1111/gbb.12239] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
209 Leibowitz SF. Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides. Physiol Behav 2007;91:513-21. [PMID: 17481672 DOI: 10.1016/j.physbeh.2007.03.018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
210 Olney JJ, Navarro M, Thiele TE. Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity. Alcohol Clin Exp Res 2015;39:21-9. [PMID: 25623402 DOI: 10.1111/acer.12591] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
211 Borgland SL, Ungless MA, Bonci A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction. Brain Res 2010;1314:139-44. [PMID: 19891960 DOI: 10.1016/j.brainres.2009.10.068] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
212 Burnette EM, Nieto SJ, Grodin EN, Meredith LR, Hurley B, Miotto K, Gillis AJ, Ray LA. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs 2022. [PMID: 35133639 DOI: 10.1007/s40265-021-01670-3] [Reference Citation Analysis]
213 Tavakkolifard M, Vousooghi N, Mahboubi S, Golab F, Ejtemaei Mehr S, Zarrindast MR. Evaluation of the relationship between the gene expression level of orexin-1 receptor in the rat blood and prefrontal cortex, novelty-seeking, and proneness to methamphetamine dependence: A candidate biomarker. Peptides 2020;131:170368. [PMID: 32668268 DOI: 10.1016/j.peptides.2020.170368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Barateau L, Jaussent I, Lopez R, Boutrel B, Leu-Semenescu S, Arnulf I, Dauvilliers Y. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. Sleep 2016;39:573-80. [PMID: 26564129 DOI: 10.5665/sleep.5530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
215 Kim JS, Martin-Fardon R. Possible Role of CRF-Hcrt Interaction in the Infralimbic Cortex in the Emergence and Maintenance of Compulsive Alcohol-Seeking Behavior. Alcohol Clin Exp Res 2020;44:354-67. [PMID: 31840823 DOI: 10.1111/acer.14264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Walker AW, Smith CM, Chua BE, Krstew EV, Zhang C, Gundlach AL, Lawrence AJ. Relaxin-3 receptor (RXFP3) signalling mediates stress-related alcohol preference in mice. PLoS One 2015;10:e0122504. [PMID: 25849482 DOI: 10.1371/journal.pone.0122504] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
217 Poceviciute I, Buisas R, Ruksenas O, Vengeliene V. Melatonin Reduces Alcohol Drinking in Rats with Disrupted Function of the Serotonergic System. JPM 2022;12:355. [DOI: 10.3390/jpm12030355] [Reference Citation Analysis]
218 Cornish J, Hunt G, Robins L, Mcgregor I. Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience 2012;206:100-14. [DOI: 10.1016/j.neuroscience.2012.01.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
219 von der Goltz C, Koopmann A, Dinter C, Richter A, Grosshans M, Fink T, Wiedemann K, Kiefer F. Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence. Horm Behav 2011;60:644-50. [PMID: 21945150 DOI: 10.1016/j.yhbeh.2011.08.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
220 Perrey DA, Zhang Y. Therapeutics development for addiction: Orexin-1 receptor antagonists. Brain Res 2020;1731:145922. [PMID: 30148984 DOI: 10.1016/j.brainres.2018.08.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
221 Nagase H, Yamamoto N, Yata M, Ohrui S, Okada T, Saitoh T, Kutsumura N, Nagumo Y, Irukayama-tomobe Y, Ishikawa Y, Ogawa Y, Hirayama S, Kuroda D, Watanabe Y, Gouda H, Yanagisawa M. Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies. J Med Chem 2017;60:1018-40. [DOI: 10.1021/acs.jmedchem.6b01418] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
222 Spanagel R. Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior. Physiological Reviews 2009;89:649-705. [DOI: 10.1152/physrev.00013.2008] [Cited by in Crossref: 434] [Cited by in F6Publishing: 415] [Article Influence: 33.4] [Reference Citation Analysis]
223 Kiefer F, Grosshans M. Beitrag der Suchtforschung zum Verständnis der Adipositas. Nervenarzt 2009;80:1040-9. [DOI: 10.1007/s00115-009-2743-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
224 Hamlin AS, Newby J, McNally GP. The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking. Neuroscience 2007;146:525-36. [PMID: 17360123 DOI: 10.1016/j.neuroscience.2007.01.063] [Cited by in Crossref: 130] [Cited by in F6Publishing: 142] [Article Influence: 8.7] [Reference Citation Analysis]
225 Sartor GC, Aston-Jones GS. A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J Neurosci 2012;32:4623-31. [PMID: 22457508 DOI: 10.1523/JNEUROSCI.4561-11.2012] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
226 Khoo SY, Gibson GD, Prasad AA, McNally GP. How contexts promote and prevent relapse to drug seeking. Genes Brain Behav 2017;16:185-204. [PMID: 27612655 DOI: 10.1111/gbb.12328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
227 Brown RM, Khoo SY, Lawrence AJ. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. International Journal of Neuropsychopharmacology 2013;16:2067-79. [DOI: 10.1017/s1461145713000333] [Cited by in Crossref: 66] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
228 Dayas CV, McGranahan TM, Martin-Fardon R, Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 2008;63:152-7. [PMID: 17570346 DOI: 10.1016/j.biopsych.2007.02.002] [Cited by in Crossref: 157] [Cited by in F6Publishing: 161] [Article Influence: 10.5] [Reference Citation Analysis]
229 Grosshans M, Loeber S, Kiefer F. Implications from addiction research towards the understanding and treatment of obesity. Addict Biol 2011;16:189-98. [PMID: 21371174 DOI: 10.1111/j.1369-1600.2010.00300.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
230 Calipari ES, España RA. Hypocretin/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms. Front Behav Neurosci 2012;6:54. [PMID: 22933994 DOI: 10.3389/fnbeh.2012.00054] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
231 Matzeu A, Martin-Fardon R. Blockade of Orexin Receptors in the Posterior Paraventricular Nucleus of the Thalamus Prevents Stress-Induced Reinstatement of Reward-Seeking Behavior in Rats With a History of Ethanol Dependence. Front Integr Neurosci 2020;14:599710. [PMID: 33240054 DOI: 10.3389/fnint.2020.599710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
232 Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
233 Uslaner JM, Winrow CJ, Gotter AL, Roecker AJ, Coleman PJ, Hutson PH, Le AD, Renger JJ. Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement. Behav Brain Res 2014;269:61-5. [PMID: 24746488 DOI: 10.1016/j.bbr.2014.04.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
234 Sirohi S, Skripnikova E, Davis JF. Vertical Sleeve Gastrectomy Attenuates Hedonic Feeding Without Impacting Alcohol Drinking in Rats. Obesity (Silver Spring) 2019;27:603-11. [PMID: 30740914 DOI: 10.1002/oby.22415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
235 Flores Á, Maldonado R, Berrendero F. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward. Biol Psychiatry 2014;75:499-507. [PMID: 23896204 DOI: 10.1016/j.biopsych.2013.06.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
236 Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
237 Amodeo LR, Wills DN, Sanchez-Alavez M, Ehlers CL. Effects of an Orexin-2 Receptor Antagonist on Sleep and Event-Related Oscillations in Female Rats Exposed to Chronic Intermittent Ethanol During Adolescence. Alcohol Clin Exp Res 2020;44:1378-88. [PMID: 32424852 DOI: 10.1111/acer.14361] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
238 Matzeu A, Zamora-Martinez ER, Martin-Fardon R. The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Front Behav Neurosci 2014;8:117. [PMID: 24765071 DOI: 10.3389/fnbeh.2014.00117] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
239 Sartor GC, Aston-Jones G. Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference. Eur J Neurosci 2012;36:3549-58. [PMID: 23039920 DOI: 10.1111/j.1460-9568.2012.08277.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
240 Olney JJ, Navarro M, Thiele TE. The Role of Orexin Signaling in the Ventral Tegmental Area and Central Amygdala in Modulating Binge-Like Ethanol Drinking Behavior. Alcohol Clin Exp Res 2017;41:551-61. [PMID: 28097729 DOI: 10.1111/acer.13336] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
241 Forget B, Pushparaj A, Le Foll B. Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biol Psychiatry 2010;68:265-71. [PMID: 20299008 DOI: 10.1016/j.biopsych.2010.01.029] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
242 Barson JR, Morganstern I, Leibowitz SF. Similarities in hypothalamic and mesocorticolimbic circuits regulating the overconsumption of food and alcohol. Physiol Behav 2011;104:128-37. [PMID: 21549731 DOI: 10.1016/j.physbeh.2011.04.054] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
243 Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. Brain Res 2012;1431:53-61. [PMID: 22133306 DOI: 10.1016/j.brainres.2011.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
244 Goodman A. Neurobiology of addiction. An integrative review. Biochem Pharmacol. 2008;75:266-322. [PMID: 17764663 DOI: 10.1016/j.bcp.2007.07.030] [Cited by in Crossref: 240] [Cited by in F6Publishing: 199] [Article Influence: 16.0] [Reference Citation Analysis]
245 Fattore L, Diana M. Drug addiction: An affective-cognitive disorder in need of a cure. Neuroscience & Biobehavioral Reviews 2016;65:341-61. [DOI: 10.1016/j.neubiorev.2016.04.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
246 Douton JE, Augusto C, Stoltzfus B, Carkaci-Salli N, Vrana KE, Grigson PS. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats. Behav Pharmacol 2021;32:265-77. [PMID: 33229892 DOI: 10.1097/FBP.0000000000000609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J Med Chem 2020;63:1528-43. [PMID: 31860301 DOI: 10.1021/acs.jmedchem.9b01787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
248 Srisontiyakul J, Kastman HE, Krstew EV, Govitrapong P, Lawrence AJ. The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats. Neurochem Res 2016;41:3206-14. [PMID: 27573375 DOI: 10.1007/s11064-016-2045-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
249 Flores A, Maldonado R, Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 2013;7:256. [PMID: 24391536 DOI: 10.3389/fnins.2013.00256] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
250 España RA. Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm 2012;89:185-208. [PMID: 22640614 DOI: 10.1016/B978-0-12-394623-2.00010-X] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
251 Walker LC, Lawrence AJ. The Role of Orexins/Hypocretins in Alcohol Use and Abuse. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 221-46. [DOI: 10.1007/7854_2016_55] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
252 Steiner N, Rossetti C, Sakurai T, Yanagisawa M, de Lecea L, Magistretti PJ, Halfon O, Boutrel B. Hypocretin/orexin deficiency decreases cocaine abuse liability. Neuropharmacology 2018;133:395-403. [PMID: 29454841 DOI: 10.1016/j.neuropharm.2018.02.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
253 Piccoli L, Micioni Di Bonaventura MV, Cifani C, Costantini VJ, Massagrande M, Montanari D, Martinelli P, Antolini M, Ciccocioppo R, Massi M, Merlo-Pich E, Di Fabio R, Corsi M. Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology 2012;37:1999-2011. [PMID: 22569505 DOI: 10.1038/npp.2012.48] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
254 Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 2007;183:43-51. [PMID: 17599478 DOI: 10.1016/j.bbr.2007.05.025] [Cited by in Crossref: 144] [Cited by in F6Publishing: 143] [Article Influence: 9.6] [Reference Citation Analysis]
255 LeSage MG, Perry JL, Kotz CM, Shelley D, Corrigall WA. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology (Berl) 2010;209:203-12. [PMID: 20177882 DOI: 10.1007/s00213-010-1792-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
256 Tabaeizadeh M, Motiei-langroudi R, Mirbaha H, Esmaeili B, Tahsili-fahadan P, Javadi-paydar M, Ghaffarpour M, Dehpour AR. The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice. Behavioural Brain Research 2013;237:41-8. [DOI: 10.1016/j.bbr.2012.09.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
257 Czora-poczwardowska K, Kujawski R, Słyńko-krzyżostaniak J, Mikołajczak PŁ, Szulc M. Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies. Postępy Higieny i Medycyny Doświadczalnej 2021;75:959-69. [DOI: 10.2478/ahem-2021-0007] [Reference Citation Analysis]
258 Morganstern I, Barson JR, Leibowitz SF. Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drug Abuse Rev 2011;4:163-73. [PMID: 21999690 DOI: 10.2174/1874473711104030163] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
259 Alcaraz-iborra M, Carvajal F, Lerma-cabrera JM, Valor LM, Cubero I. Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: Pharmacological and molecular evidence of orexin involvement. Behavioural Brain Research 2014;272:93-9. [DOI: 10.1016/j.bbr.2014.06.049] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
260 Hrabovszky E, Molnár CS, Borsay BÁ, Gergely P, Herczeg L, Liposits Z. Orexinergic input to dopaminergic neurons of the human ventral tegmental area. PLoS One 2013;8:e83029. [PMID: 24376626 DOI: 10.1371/journal.pone.0083029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
261 Hao H, Luan X, Guo F, Sun X, Gong Y, Xu L. Lateral hypothalamic area orexin-A influence the firing activity of gastric distension-sensitive neurons and gastric motility in rats. Neuropeptides 2016;57:45-52. [PMID: 26919916 DOI: 10.1016/j.npep.2016.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
262 Millan EZ, Marchant NJ, McNally GP. Extinction of drug seeking. Behav Brain Res 2011;217:454-62. [PMID: 21073904 DOI: 10.1016/j.bbr.2010.10.037] [Cited by in Crossref: 79] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
263 Zhang XY, Yu L, Zhuang QX, Zhu JN, Wang JJ. Central functions of the orexinergic system. Neurosci Bull 2013;29:355-65. [PMID: 23299718 DOI: 10.1007/s12264-012-1297-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
264 Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011;51:243-66. [PMID: 21034217 DOI: 10.1146/annurev-pharmtox-010510-100528] [Cited by in Crossref: 202] [Cited by in F6Publishing: 194] [Article Influence: 18.4] [Reference Citation Analysis]
265 Ziółkowski M, Czarnecki D, Budzyński J, Rosińska Z, Żekanowska E, Góralczyk B. Orexin in Patients with Alcohol Dependence Treated for Relapse Prevention: A Pilot Study. Alcohol Alcohol 2016;51:416-21. [PMID: 26597795 DOI: 10.1093/alcalc/agv129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
266 Rao Y, Mineur YS, Gan G, Wang AH, Liu ZW, Wu X, Suyama S, de Lecea L, Horvath TL, Picciotto MR, Gao XB. Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice. J Physiol 2013;591:1951-66. [PMID: 23318871 DOI: 10.1113/jphysiol.2012.246983] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
267 McNally GP. Extinction of drug seeking: Neural circuits and approaches to augmentation. Neuropharmacology 2014;76 Pt B:528-32. [PMID: 23774135 DOI: 10.1016/j.neuropharm.2013.06.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
268 Karatayev O, Lukatskaya O, Moon SH, Guo WR, Chen D, Algava D, Abedi S, Leibowitz SF. Nicotine and ethanol co-use in Long-Evans rats: Stimulatory effects of perinatal exposure to a fat-rich diet. Alcohol 2015;49:479-89. [PMID: 25979531 DOI: 10.1016/j.alcohol.2015.03.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
269 Boss C, Brisbare-Roch C, Jenck F. Biomedical application of orexin/hypocretin receptor ligands in neuroscience. J Med Chem 2009;52:891-903. [PMID: 19199652 DOI: 10.1021/jm801296d] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
270 [DOI: 10.1101/2020.04.25.061887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
271 Khoo SY, Clemens KJ, Mcnally GP. Palatable food self-administration and reinstatement are not affected by dual orexin receptor antagonism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;87:147-57. [DOI: 10.1016/j.pnpbp.2017.06.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
272 McElhinny CJ Jr, Lewin AH, Mascarella SW, Runyon S, Brieaddy L, Carroll FI. Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible confounding effects on in vivo and in vitro studies. Bioorg Med Chem Lett 2012;22:6661-4. [PMID: 23031594 DOI: 10.1016/j.bmcl.2012.08.109] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
273 Lebold TP, Bonaventure P, Shireman BT. Selective orexin receptor antagonists. Bioorg Med Chem Lett 2013;23:4761-9. [PMID: 23891187 DOI: 10.1016/j.bmcl.2013.06.057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
274 Zhou L, Sun WL, See RE. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction. Pharmaceuticals (Basel) 2011;4:804-21. [PMID: 23997653 DOI: 10.3390/ph4060804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
275 Feltenstein MW, See RE. Systems level neuroplasticity in drug addiction. Cold Spring Harb Perspect Med 2013;3:a011916. [PMID: 23580792 DOI: 10.1101/cshperspect.a011916] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
276 Anderson RI, Moorman DE, Becker HC. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol. Handb Exp Pharmacol 2018;248:473-503. [PMID: 29526023 DOI: 10.1007/164_2018_100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
277 Berizzi AE, Perry CJ, Shackleford DM, Lindsley CW, Jones CK, Chen NA, Sexton PM, Christopoulos A, Langmead CJ, Lawrence AJ. Muscarinic M5 receptors modulate ethanol seeking in rats. Neuropsychopharmacology 2018;43:1510-7. [PMID: 29483658 DOI: 10.1038/s41386-017-0007-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
278 McClintick JN, McBride WJ, Bell RL, Ding ZM, Liu Y, Xuei X, Edenberg HJ. Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking. Pharmacol Biochem Behav 2015;129:87-96. [PMID: 25542586 DOI: 10.1016/j.pbb.2014.12.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
279 Yeoh JW, James MH, Jobling P, Bains JS, Graham BA, Dayas CV. Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus. J Physiol 2012;590:3677-89. [PMID: 22641785 DOI: 10.1113/jphysiol.2012.230268] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
280 James MH, Fragale JE, O'Connor SL, Zimmer BA, Aston-Jones G. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse. Neuropharmacology 2021;183:108359. [PMID: 33091458 DOI: 10.1016/j.neuropharm.2020.108359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
281 Feltenstein MW, See RE, Fuchs RA. Neural Substrates and Circuits of Drug Addiction. Cold Spring Harb Perspect Med 2021;11:a039628. [PMID: 32205414 DOI: 10.1101/cshperspect.a039628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
282 Aston-Jones G, Smith RJ, Moorman DE, Richardson KA. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009;56 Suppl 1:112-21. [PMID: 18655797 DOI: 10.1016/j.neuropharm.2008.06.060] [Cited by in Crossref: 188] [Cited by in F6Publishing: 191] [Article Influence: 13.4] [Reference Citation Analysis]
283 Baimel C, Borgland SL, Corrigall W. Cocaine and Nicotine Research Illustrates a Range of Hypocretin Mechanisms in Addiction. Sleep Hormones. Elsevier; 2012. pp. 291-313. [DOI: 10.1016/b978-0-12-394623-2.00016-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
284 Bonci A, Borgland S. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 2009;56:107-11. [DOI: 10.1016/j.neuropharm.2008.07.024] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
285 Zhou L, Ghee SM, Chan C, Lin L, Cameron MD, Kenny PJ, See RE. Orexin-1 receptor mediation of cocaine seeking in male and female rats. J Pharmacol Exp Ther 2012;340:801-9. [PMID: 22186370 DOI: 10.1124/jpet.111.187567] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]